购物车
- 全部删除
- 您的购物车当前为空
GSK1733953A 可作为一种小分子结核分枝杆菌呼吸抑制剂,对 MenG 活性有抑制作用,IC50 值为 2.6 ± 0.6 μM。GSK1733953A 是一种具有选择性的联苯苯甲酰胺,对结核分枝杆菌去甲基萘醌甲基转移酶的催化甲基化有抑制作用,对结核分枝杆菌H4Rv的MIC为8.37 μg/ml,对耐药菌株的MIC为1.2至9.6 μg/ml。GSK1733953A 是治疗结核病的候选化合物。
GSK1733953A 可作为一种小分子结核分枝杆菌呼吸抑制剂,对 MenG 活性有抑制作用,IC50 值为 2.6 ± 0.6 μM。GSK1733953A 是一种具有选择性的联苯苯甲酰胺,对结核分枝杆菌去甲基萘醌甲基转移酶的催化甲基化有抑制作用,对结核分枝杆菌H4Rv的MIC为8.37 μg/ml,对耐药菌株的MIC为1.2至9.6 μg/ml。GSK1733953A 是治疗结核病的候选化合物。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥ 283 | 现货 | |
25 mg | ¥ 455 | 现货 | |
50 mg | ¥ 747 | 现货 |
产品描述 | GSK1733953A can be used as a small molecule Mycobacterium tuberculosis respiration inhibitor with an inhibitory effect on MenG activity and an IC50 value of 2.6 ± 0.6 μM.GSK1733953A is a selective biphenylbenzamide with an inhibitory effect on the catalytic methylation of the Mycobacterium tuberculosis desmethylnaphthoquinone methyltransferase, and the MIC of GSK1733953A against Mycobacterium tuberculosis H4Rv was 8.37 μg/ml. MIC of 8.37 μg/ml and MIC of 1.2 to 9.6 μg/ml against drug-resistant strains.GSK1733953A is a candidate compound for the treatment of tuberculosis. |
靶点活性 | MenG:2.6 ± 0.6 μM |
别名 | DG70 |
分子量 | 385.82 |
分子式 | C21H17ClFNO3 |
CAS No. | 930470-97-6 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 40 mg/mL (103.68 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.